Biotech Company Seeks Volunteers For Stem Cell Trials On Age-Related Diseases Including Alzheimer's

  • 📰 Forbes
  • ⏱ Reading Time:
  • 34 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 53%

日本 ニュース ニュース

日本 最新ニュース,日本 見出し

“One of the most exciting ideas emerging from the field of regenerative medicine is the theory that stem cells may prevent, treat or possibly even reverse aging-related disability and frailty,' said Geoff Green, Senior Vice President of Clinical Operations at Longeveron.

“Stem cell therapy is a promising new treatment option under clinical study for chronic diseases and injuries affecting various organ systems,” said Geoff Green, Senior Vice President of Clinical Operations at Longeveron. “One of the most exciting ideas emerging from the field of regenerative medicine is the theory that stem cells may prevent, treat or possibly even reverse aging-related disability and frailty.

Green said the company’s US clinical studies are conducted under the approval of the FDA per Investigational New Drug applications, “meaning we are held to and comply with strict regulatory requirements," he said."This is intended to give patients and physicians confidence that the product is made according to the existing standards in place that regulate the clinical testing of allogeneic stem cells.

“Stem cells have been called everything from cure-alls to miracle treatments. But don’t believe the hype,” Sometimes called the body’s “master cells,” stem cells are the cells that develop into blood, brain, bones and all of the body’s organs.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 394. in JP
 

コメントありがとうございます。コメントは審査後に公開されます。

日本 最新ニュース, 日本 見出し